Navigation Links
Celleration, Inc. Announces First Patient Enrollment in In-Balance VLU Randomized Control Trial
Date:5/14/2012

EDEN PRAIRIE, Minn., May 14, 2012 /PRNewswire/ -- Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the first patient enrollment in IN-BALANCE VLU (Inflammation, Bacteria, & Angiogenesis effects in Launching Venous Leg Ulcer healing: A Clinical Evaluation).  IN-BALANCE VLU is designed to expand on the vast body of evidence on MIST Therapy® that currently includes 12 peer-reviewed studies and a 444 patient meta-analysis supporting the clinical and economic benefits of the FDA cleared wound healing therapy.

IN-BALANCE VLU is a prospective, randomized, controlled, multi-center study of MIST Therapy in chronic lower extremity venous ulcers ("VLU").  The study will compare the effect of MIST Therapy on wound healing rates to traditional standard of care. The study will be performed at up to 20 study centers with an estimated 124 subjects enrolled in the study overall.  This study also includes sub-analyses of fluid and tissue samples to characterize cellular and molecular changes surrounding inflammation, angiogenesis and bio-burden impact of the treatments.

Venous leg ulcers are estimated to cost the U.S. healthcare system approximately $2-$3 billion annually and cause the loss of approximately two million working days per year. "With the significant economic and social cost of wound care rapidly rising, we must focus on conducting rigorous studies to fully understand both the biological mechanisms and healing outcomes of the many wound care treatment options to ensure we are selecting the most clinically efficacious and cost-effective treatment for each unique patient and wound," commented Gary Gibbons, MD, South Shore Hospital Center for Wound Care and Hyperbaric Medicine, Weymouth, MA.  "Celleration's IN-BALANCE VLU
'/>"/>

SOURCE Celleration, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Celleration, Inc. Announces Close of $8 Million Series E Financing
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
(Date:6/17/2013)... , June 17, 2013 DNAtrix Inc., experts ... will present clinical data on the company,s lead product, ... Quebec City, Canada on June ... DNAtrix,s CEO and a leader in the field of ... study entitled A PHASE I TRIAL OF A CONDITIONALLY ...
(Date:6/17/2013)... The following is a Statement of Steve Pasierb , ... Last Friday, Urban Outfitters issued a ... prescription drug paraphernalia products. The statement read, "In this extensive ... there may be individual items that are misinterpreted by people ... misinterpretation we are electing to discontinue these few styles from ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales 2
... HealthWarehouse.com, Inc. (ticker: HEWA) a leading VIPPS-accredited, ... President and CEO, will present at RetailInvestorConferences.com. Company ... virtual conference.DATE: , May 5, 2011TIME: ... the red "register/ watch event now" button.This will ...
... OMCL ), a leading global provider of system ... first quarter ended March 31, 2011. GAAP results: ... million as compared with $57.3 million for the fourth quarter ... first quarter 2010 revenue of $54.2 million. Net ...
Cached Medicine Technology:HealthWarehouse.com, Inc. to Present Live at RetailInvestorConferences.com on May 5th 2Omnicell Announces First Quarter 2011 Results 2Omnicell Announces First Quarter 2011 Results 3Omnicell Announces First Quarter 2011 Results 4Omnicell Announces First Quarter 2011 Results 5Omnicell Announces First Quarter 2011 Results 6Omnicell Announces First Quarter 2011 Results 7Omnicell Announces First Quarter 2011 Results 8Omnicell Announces First Quarter 2011 Results 9Omnicell Announces First Quarter 2011 Results 10
(Date:6/18/2013)... using technology developed at Case Western Reserve University,s ... of Engineering, has made available avatarsvirtual patientsto train ... and others training to evaluate speech-language disorders to ... on the trainee, because a diagnosis doesn,t have ... , Graduate students studying to become speech-language pathologists ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The Elizabeth ... of State and the U.S. President’s Emergency Plan for ... and celebrate significant new milestones in the global effort ... John Kerry announced that as of June 2013, one ... PEPFAR support. Since PEPFAR’s inception in 2003, EGPAF ...
(Date:6/18/2013)... 18, 2013 A new $119 million ... burgeoning aquaculture industry is redefining the way consumers get ... most acclaimed personal culinary chefs on the Emerald Coast ... of sustainable seafood and the promising industry of aquaculture. ... days. Many consumers strive to fully partake in the ...
(Date:6/18/2013)... New York magazine named 145 physicians from ... list, up from 129 last year and more than any ... lists 52 additional doctors who serve at hospitals within Mount ... The “Best Doctors” issue, which this year features a total ... and is available online at http://www.nymag.com/bestdoctors . , “America ...
(Date:6/18/2013)... their scheduled medical appointments and their disease under ... things clearly and knows them as a person, not ... "If people feel their doctor really knows them and ... best interests at heart and may be more likely ... Flickinger, M.D., M.P.H., a fellow in the Division of ...
Breaking Medicine News(10 mins):Health News:SimuCase avatars advance speech-language pathology training 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Respect may be the key to stopping patient 'no shows' 2
... Finding could lead to earlier, more effective treatment: researchers ... have found a way to detect muscular dystrophy in ... time to treat the disease before symptoms develop. , ... disrupted stem-cell function and delays of skeletal-muscle formation in ...
... is providing distant nursing home patients with Parkinson,s disease access ... A pilot study of the project the results of ... Parkinson,s Disease and Movement Disorders in Paris demonstrates that ... function of patients. "This study shows that ...
... ... at Falcon Field, it was jointly announced today by Air Force Director of Athletics Dr. ... ... FieldTurf at Falcon Field, it was jointly announced today by Air Force Director of ...
... Kendle (Nasdaq: KNDL ), a leading, ... of its executives will present on important industry issues ... June 21-25, 2009, in San Diego, Calif. Kendle experts ... issues in portfolio management, pregnancy registries and risk management, ...
... kicks-off June 19 at the United Nations , , NEW YORK, June 17 ... , Performance by Ruben Studdard, including the world premiere of ... United Nations declaration of World Sickle Cell Day , ... Smart program , Free screenings for a serious ...
... North Carolina State University and the National Institute of ... in rats that have been exposed to bisphenol-A (BPA) ... has been thought not to produce any adverse effects. ... water bottles, canned foods and an array of other ...
Cached Medicine News:Health News:Clues to Muscular Dystrophy Seen in Womb 2Health News:Telemedicine expands reach of care for Parkinson's patients 2Health News:Telemedicine expands reach of care for Parkinson's patients 3Health News:Air Force to Install Fieldturf at Falcon Field 2Health News:Air Force to Install Fieldturf at Falcon Field 3Health News:Kendle to Share Insights at Drug Information Association 45th Annual Meeting 2Health News:Kendle to Share Insights at Drug Information Association 45th Annual Meeting 3Health News:Ruben Studdard, American Idol Winner and R&B Pop Star, Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 2Health News:Ruben Studdard, American Idol Winner and R&B Pop Star, Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 3Health News:Study finds reproductive health effects from low doses of bisphenol-A 2
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Narrow 4 mm long smooth platform. Serrated handle with polished finish....
Fine 2 mm wide platform. Cross action serrated handle with metal tip guard. Polished finish....
Oval solid 24 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 20 mm. Serrated handle with locking thumb screw and polished finish....
Medicine Products: